Rockefeller Capital Management
BBP icon

Rockefeller Capital Management’s Virtus Biotech ETF BBP Stock Holding History

Rockefeller Capital Management’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24,073
Closed -$1.19M – 2145
2022
Q4 		$1.19M Sell
24,073
-3,334
-12% -$160K 0.01% 944
2022
Q3 		$1.24M Buy
+27,407
New +$1.27M 0.01% 935

Other funds holding BBP

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
DSC
Duncker Streett & Co St. Louis, Missouri $526M AUM 22.2% 1-Year Est. Return

Rockefeller Capital Management's BBP Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Virtus Biotech ETF (BBP) in Q1 2023, closing a stake of 24,073 shares — an estimated $1.19M sold.

Rockefeller Capital Management first reported a position in BBP in Q3 2022 and held it in 2 quarters. The position peaked at $1.24M in Q3 2022. 14 funds tracked by Wall St. Rank hold BBP as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Virtus Biotech ETF position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 24,073 Virtus Biotech ETF shares in Q1 2023, an estimated $1.19M.
  • Rockefeller Capital Management first reported a position in Virtus Biotech ETF in Q3 2022 and held it in 2 quarters.
  • Rockefeller Capital Management's Virtus Biotech ETF position peaked at $1.24M in Q3 2022.
  • 14 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.